The History of Research on Coronary Stenting

  • Fabrizio Tomai
  • Leonardo De Luca


There are few technical developments that have changed the face of interventional cardiology as much and as rapidly as the practice of the placement of intracoronary stents. The first stents were implanted in the coronary arteries of humans more than 20 years ago; since then, there have been significant developments in their technology, the most notable of which has been the introduction of drug-eluting stents. Nowadays, newer stents have been developed that are currently undergoing pre-clinical and clinical trials with promising early results.


Stent Thrombosis Coronary Stents Target Lesion Revascularization Restenosis Rate Coronary Artery Aneurysm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mueller RL, Sanborn TA (1995) The history of interventional cardiology: cardiac catheterization, angioplasty, and related interventions. Am Heart J 129:146–172PubMedCrossRefGoogle Scholar
  2. 2.
    Gruntzig A (1978) Transluminal dilatation of coronary-artery stenosis. Lancet 1:263PubMedCrossRefGoogle Scholar
  3. 3.
    Gruntzig AR, Senning A, Siegenthaler WE (1979) Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301:61–68PubMedCrossRefGoogle Scholar
  4. 4.
    Nobel’s Lectures (1967) Physiology or Medicine 1901–1921. Elsevier Publishing Company, AmsterdamGoogle Scholar
  5. 5.
    Dotter CT, Judkins MP (1964) Transluminal treatment of arteriosclerotic obstruction. Description of a new technique and a preliminary report of its application. Circulation 30:654–670PubMedCrossRefGoogle Scholar
  6. 6.
    Rousseau H, Puel J, Joffre F et al (1987) Self-expanding endovascular prosthesis: an experimental study. Radiology 164:709–714PubMedGoogle Scholar
  7. 7.
    Palmaz JC, Sibbitt RR, Reuter SR et al (1985) Expandable intraluminal graft: a preliminary study. Work in progress. Radiology 156:73–77PubMedGoogle Scholar
  8. 8.
    Schatz RA, Palmaz JC, Tio FO et al (1987) Balloon-expandable intracoronary stents in the adult dog. Circulation 76:450–457PubMedCrossRefGoogle Scholar
  9. 9.
    Sigwart U, Puel J, Mirkovitch V et al (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316:701–706PubMedCrossRefGoogle Scholar
  10. 10.
    De Feyter PJ, de Jaegere PP, Serruys PW (1994) Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty. Am Heart J 127:643–651PubMedCrossRefGoogle Scholar
  11. 11.
    Roubin GS, Cannon AD, Agrawal SK et al (1992) Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 85:916–927PubMedCrossRefGoogle Scholar
  12. 12.
    Serruys PW, de Jaegere P, Kiemeneij F, The Benestent Study Group et al (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331:489–495PubMedCrossRefGoogle Scholar
  13. 13.
    Fischman DL, Leon MB, Baim DS, The stent restenosis study investigators et al (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent restenosis study investigators. N Engl J Med 331:496–501PubMedCrossRefGoogle Scholar
  14. 14.
    Versaci F, Gaspardone A, Tomai F et al (1997) A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. N Engl J Med 336:817–822PubMedCrossRefGoogle Scholar
  15. 15.
    Serruys PW, Strauss BH, Beatt KJ et al (1991) Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med 324:13–17PubMedCrossRefGoogle Scholar
  16. 16.
    Schomig A, Neumann FJ, Kastrati A et al (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 334:1084–1089PubMedCrossRefGoogle Scholar
  17. 17.
    Moliterno DJ (2005) Healing Achilles–sirolimus versus paclitaxel. N Engl J Med 353:724–727PubMedCrossRefGoogle Scholar
  18. 18.
    Hoffmann R, Mintz GS (2000) Coronary in-stent restenosis—predictors, treatment and prevention. Eur Heart J 21:1739–1749PubMedCrossRefGoogle Scholar
  19. 19.
    Hirshfeld JW Jr, Schwartz JS, Jugo R, The M-heart investigators et al (1991) Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-heart investigators. J Am Coll Cardiol 18:647–656PubMedCrossRefGoogle Scholar
  20. 20.
    Ribichini F, Tomai F, De Luca G et al (2011) CEREA-DES investigators. Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. Am J Med 124:434–43Google Scholar
  21. 21.
    Woods TC, Marks AR (2004) Drug-eluting stents. Annu Rev Med 55:169–178PubMedCrossRefGoogle Scholar
  22. 22.
    Dangas GD, Claessen BE, Caixeta A et al (2010) In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 56:1897–1907PubMedCrossRefGoogle Scholar
  23. 23.
    Tomai F, Petrolini A, De Luca L et al (2010) Rationale and design of the randomized comparison of XiEnce V and Multilink VisioN coronary stents in the sAme muLtivessel patient with chronic kidney disease (RENAL-DES) study. J Cardiovasc Med 11:310–317CrossRefGoogle Scholar
  24. 24.
    Tomai F, Reimers B, De Luca L et al (2008) Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study. Diabetes Care 31:15–19PubMedCrossRefGoogle Scholar
  25. 25.
    Hill RA, Dundar Y, Bakhai A et al (2004) Drug eluting stents: an early systematic review to inform policy. Eur Heart J 25:902–919PubMedCrossRefGoogle Scholar
  26. 26.
    Stone GW, Moses JW, Ellis SG et al (2007) Safety and efficacy of sirolimus- and paclitaxel eluting coronary stents. N Engl J Med 356:998–1008PubMedCrossRefGoogle Scholar
  27. 27.
    Kastrati A, Dibra A, Eberle S et al (2005) Sirolimus-eluting stents vs paclitaxel eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 294:819–825PubMedCrossRefGoogle Scholar
  28. 28.
    Kastrati A, Mehilli J, Pache J et al (2007) Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356:1030–1039PubMedCrossRefGoogle Scholar
  29. 29.
    Kirtane AJ, Gupta A, Iyengar S et al (2009) Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 119:3198–3206PubMedCrossRefGoogle Scholar
  30. 30.
    Stettler C, Wandel S, Allemann S et al (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937–948PubMedCrossRefGoogle Scholar
  31. 31.
    Win HK, Caldera AE, Maresh K et al (2007) Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297:2001–2009PubMedCrossRefGoogle Scholar
  32. 32.
    Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130PubMedCrossRefGoogle Scholar
  33. 33.
    Serruys PW, Daemen J (2007) Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 115:1433–1439PubMedCrossRefGoogle Scholar
  34. 34.
    Kuchulakanti PK, Chu WW, Torguson R et al (2006) Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113:1108–1113PubMedCrossRefGoogle Scholar
  35. 35.
    Roukoz H, Bavry AA, Sarkees ML et al (2009) Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am J Med 122(581):e1–e10PubMedGoogle Scholar
  36. 36.
    Nakazawa G, Finn AV, Vorpahl M et al (2009) Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol 54:1924–1931PubMedCrossRefGoogle Scholar
  37. 37.
    Aoki J, Kirtane A, Leon MB et al (2008) Coronary artery aneurysms after drug-eluting stent implantation. J Am Coll Cardiol Intv 1:14–21CrossRefGoogle Scholar
  38. 38.
    Alfonso F, Perez-Vizcayno MJ, Ruiz M et al (2009) Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol 53:2053–2060PubMedCrossRefGoogle Scholar
  39. 39.
    Eisenstein EL, Leon MB, Kandzari DE et al (2009) Long-term clinical and economic analysis of the endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent 3 year results from the ENDEAVOR III trial (randomized controlled trial of the Medtronic Endeavor drug [ABT-578] eluting coronary stent system versus the cypher sirolimus-eluting coronary stent system in de novo native coronary artery lesions). J Am Coll Cardiol Intv 2:1199–1207CrossRefGoogle Scholar
  40. 40.
    Leon MB, Mauri L, Popma JJ et al (2010) A randomised comparison of the endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel eluting stent in de novo native coronary lesions: 12 month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol 55:543–554PubMedCrossRefGoogle Scholar
  41. 41.
    Stone GW, Midei M, Newman W et al (2008) Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 299:1903–1913PubMedCrossRefGoogle Scholar
  42. 42.
    Kedhi E, Joesoef KS, McFadden E et al (2010) Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 375:201–209PubMedCrossRefGoogle Scholar
  43. 43.
    Latib A, Colombo A, Sangiorgi SM (2009) Bifurcation stenting: current strategies and new devices. Heart 95:495–504PubMedCrossRefGoogle Scholar
  44. 44.
    Verheye S, Agostoni P, Dubois CL et al (2009) 9 month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-eluting stent intervention for treating side branches effectively) study. J Am Coll Cardiol 53:1031–1039PubMedCrossRefGoogle Scholar
  45. 45.
    Garg S, Serruys PW (2010) Coronary stents: looking forward. J Am Coll Cardiol 56:S43–S78PubMedCrossRefGoogle Scholar
  46. 46.
    Windecker S, Serruys PW, Wandel S et al (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomized non-inferiority trial. Lancet 372:1163–1173PubMedCrossRefGoogle Scholar
  47. 47.
    Byrne RA, Kufner S, Tiroch K et al (2009) Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2 year follow-up results. Heart 95:1489–1494PubMedCrossRefGoogle Scholar
  48. 48.
    Ormiston JA, Serruys PWS (2009) Bioabsorbable coronary stents. Circ Cardiovasc Interv 2:255–260PubMedCrossRefGoogle Scholar
  49. 49.
    Serruys PW, Ormiston JA, Onuma Y et al (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2 year outcomes and results from multiple imaging methods. Lancet 373:897–910PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2013

Authors and Affiliations

  1. 1.Department of Cardiovascular Sciences, Interventional Cardiology UnitEuropean HospitalRomeItaly

Personalised recommendations